Pivonello, R. Et Al. 2017. Pasireotide alone or in combination with cabergoline effectively controls urinary free cortisol levels: results from a prospective study in patients with Cushing’s disease (CAPACITY). 19th Euroepan Congress of Endocrinology , (Lizbon, Portugal).

Pivonello, R., bex, m., KADIOĞLU, P., Dyenira, G., Buguszewski, C., YAVUZ, D., ... Patino, H.(2017). Pasireotide alone or in combination with cabergoline effectively controls urinary free cortisol levels: results from a prospective study in patients with Cushing’s disease (CAPACITY) . 19th Euroepan Congress of Endocrinology, Lizbon, Portugal

Pivonello, Rosario Et Al. "Pasireotide alone or in combination with cabergoline effectively controls urinary free cortisol levels: results from a prospective study in patients with Cushing’s disease (CAPACITY)," 19th Euroepan Congress of Endocrinology, Lizbon, Portugal, 2017

Pivonello, Rosario Et Al. "Pasireotide alone or in combination with cabergoline effectively controls urinary free cortisol levels: results from a prospective study in patients with Cushing’s disease (CAPACITY)." 19th Euroepan Congress of Endocrinology , Lizbon, Portugal, 2017

Pivonello, R. Et Al. (2017) . "Pasireotide alone or in combination with cabergoline effectively controls urinary free cortisol levels: results from a prospective study in patients with Cushing’s disease (CAPACITY)." 19th Euroepan Congress of Endocrinology , Lizbon, Portugal.

@conferencepaper{conferencepaper, author={Rosario Pivonello Et Al. }, title={Pasireotide alone or in combination with cabergoline effectively controls urinary free cortisol levels: results from a prospective study in patients with Cushing’s disease (CAPACITY)}, congress name={19th Euroepan Congress of Endocrinology}, city={Lizbon}, country={Portugal}, year={2017}}